Search results for "metabolic"

showing 10 items of 2205 documents

Alterations in Lipid and Carbohydrate Metabolism in Patients with Classic Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency

2009

<i>Background:</i> Classic 21-hydroxylase deficiency (21HD) presents some traits of the metabolic syndrome. <i>Aim:</i> To characterize discrete alterations of lipid and carbohydrate metabolism in children and young adults with classic 21HD, which could predict early atherogenesis. <i>Patients and Methods:</i> Twenty-seven Caucasian patients with classic 21HD (4–31 years); 27 sex-, age- and BMI-matched controls. Clinical parameters, hormonal status and genotype were assessed in all patients. Lipid parameters, including relative (%) and absolute (mg/dl) small-dense low-density lipoproteins subfractions (sd-LDL) were measured in patients and controls. Oral …

AdultBlood GlucoseMalemedicine.medical_specialtyAdolescentEndocrinology Diabetes and MetabolismCarbohydrate metabolismStatistics NonparametricYoung Adultchemistry.chemical_compoundEndocrinologyInternal medicinemedicineHumansInsulinIn patientChildTriglyceridesGlucose tolerance testAdrenal Hyperplasia CongenitalC-Peptidebiologymedicine.diagnostic_testCholesterolCholesterol HDL21-HydroxylaseCholesterol LDLGlucose Tolerance TestHyperplasiaLipid Metabolismmedicine.diseaseCross-Sectional StudiesEndocrinologychemistryChild PreschoolLow-density lipoproteinPediatrics Perinatology and Child Healthbiology.proteinCarbohydrate MetabolismFemaleSteroid 21-HydroxylaseInsulin ResistanceMetabolic syndromeHormone Research in Paediatrics
researchProduct

Effects of muscular exercise on erythrocyte adenosine triphosphate concentration in patients with insulin-dependent diabetes mellitus.

1987

Type I diabetes mellitus represents a metabolic disorder in which intracellular glycolytic pathway is inhibited by insulin deficiency, with the subsequent decreased availability of energetic substrates such as ATP. Some aspects of the energetic metabolism in response to an intensive demand (muscular exercise) were investigated, in a group of 10 ketotic diabetic patients, by measuring erythrocyte adenosine triphosphate (ATP) and blood glucose, free fatty acids (FFA) and lactate levels. In the diabetic subjects, in comparison with normal subjects, the decreased levels of erythrocyte ATP at rest did not increase after exercise, while the increased levels of FFA at rest did not diminish after e…

AdultBlood GlucoseMalemedicine.medical_specialtyContraction (grammar)ErythrocytesClinical BiochemistryPhysical ExertionFatty Acids NonesterifiedDiabetic Ketoacidosischemistry.chemical_compoundAdenosine TriphosphateInternal medicinemedicineHumansGlycolysisIn patientHematologyChemistryMusclesMetabolic disorderMetabolismmedicine.diseaseEndocrinologyDiabetes Mellitus Type 1LactatesFemaleEnergy MetabolismAdenosine triphosphateIntracellularLa Ricerca in clinica e in laboratorio
researchProduct

The effects of muscular exercise on glucose, free fatty acids, alanine and lactate in type I diabetic subjects in relation to metabolic control.

1988

Metabolic effects of muscular exercise were studied in eleven subjects with type I diabetes mellitus during poor metabolic control, and again during good metabolic control, and in ten healthy control subjects. All the subjects were submitted to a submaximal gradual triangular test on an electrically braked bicycle ergometer; glucose, FFA, alanine and lactate were measured at rest, and after exercise. In poorly controlled patients, glucose and FFA were unchanged after exercise, whereas blood alanine and lactate increased by a percentage similar to that of the controls, and well-controlled diabetic patients. Baseline alanine concentrations were lower and lactate concentrations higher than in …

AdultBlood GlucoseMalemedicine.medical_specialtyEndocrinology Diabetes and MetabolismFatty Acids NonesterifiedEndocrinologyReference ValuesInternal medicineDiabetes mellitusHealthy controlInternal MedicinemedicineHumansExerciseAlanineAlanineC-Peptidebusiness.industryType i diabetes mellitusGeneral Medicinemedicine.diseaseEndocrinologyDiabetes Mellitus Type 1Metabolic control analysisMetabolic effectsLactatesFemaleBicycle ergometerbusinessActa diabetologica latina
researchProduct

Clinical and metabolic effects of first-line treatment with somatostatin analogues or surgery in acromegaly: a retrospective and comparative study.

2012

To evaluate the metabolic effects of first-line somatostatin analogues or surgery in acromegaly. Retrospective, comparative, 12-month follow-up. Two hundred and thirty one patients (123 men, age 47.32 ± 14.63 years) with active acromegaly, first line treatments were somatostatin analogues in 151 (65.4%) and surgery in 80 (34.6%). Metabolic syndrome (MS) parameters, glucose, insulin and GH during oral glucose tolerance test, stimulated insulin sensitivity by insulin sensitivity index (ISI Matsuda), early and total insulin-secretion rate by insulinogenic index and AUC(INS), visceral adiposity function, expressed by visceral adipose index (VAI). Somatostatin analogues treatment improved all MS…

AdultBlood GlucoseMalemedicine.medical_specialtyEndocrinology Diabetes and Metabolismmedicine.medical_treatmentsomatostatin analogueSettore MED/13 - EndocrinologiasurgeryYoung AdultEndocrinologyInternal medicineAcromegalyMedicineHumansYoung adultInsulin-Like Growth Factor IAgedRetrospective StudiesAged 80 and overbusiness.industryHuman Growth HormoneInsulinRetrospective cohort studyMiddle Agedmedicine.diseaseSurgeryFirst line treatmentSomatostatinEndocrinologyMetabolic effectsAcromegalyacromegaly; somatostatin analogues; metabolismFemaleMetabolic syndromebusinessSomatostatinmetabolismPituitary
researchProduct

Influence of glucose control and improvement of insulin resistance on microvascular blood flow and endothelial function in patients with diabetes mel…

2005

The study was performed to investigate the effect of improving metabolic control with pioglitazone in comparison to glimepiride on microvascular function in patients with diabetes mellitus type 2.A total of 179 patients were recruited and randomly assigned to one treatment group. Metabolic control (HbA1c), insulin resistance (HOMA index), and microvascular function (laser Doppler fluxmetry) were observed at baseline and after 3 and 6 months.HbA1c improved in both treatment arms (pioglitazone: 7.52 +/- 0.85% to 6.71 +/- 0.89%, p.0001; glimepiride: 7.44 +/- 0.89% to 6.83 +/- 0.85%, p.0001). Insulin-resistance decreased significantly in the pioglitazone group (6.15 +/- 4.05 to 3.85 +/- 1.92, p…

AdultBlood GlucoseMalemedicine.medical_specialtyEndotheliumPhysiologyArbitrary unitInsulin resistancePhysiology (medical)Diabetes mellitusInternal medicinemedicineHumansHypoglycemic AgentsMolecular BiologyAgedPioglitazonebusiness.industryMicrocirculationGlucose clamp techniqueMiddle Agedmedicine.diseaseGlimepirideEndocrinologymedicine.anatomical_structureSulfonylurea CompoundsDiabetes Mellitus Type 2Metabolic control analysisGlucose Clamp TechniqueFemaleThiazolidinedionesEndothelium VascularInsulin ResistanceCardiology and Cardiovascular MedicinebusinessPioglitazoneBlood Flow Velocitymedicine.drugMicrocirculation (New York, N.Y. : 1994)
researchProduct

The metabolic syndrome predicts cardiovascular events in subjects with normal fasting glucose: results of a 15 years follow-up in a Mediterranean pop…

2006

The aim of this study was to evaluate the cardiovascular (CV) risk due to the metabolic syndrome in a 15-year prospective study of a Sicilian population. In the Mediterranean area obesity is highly prevalent, but epidemiological data on the metabolic syndrome are limited. Methods and results: Among the 1351 subjects enrolled in the “Ventimiglia di Sicilia” epidemiological project, we selected 687 subjects between 35 and 75 years of age; baseline parameters were assessed and subjects have been followed for 15 years recording CV events, total and cardiovascular mortality. The metabolic syndrome was defined according to both the Adult Treatment Panel III and the International Diabetes Federati…

AdultBlood GlucoseMalemedicine.medical_specialtyEpidemiologyPopulationMyocardial InfarctionCoronary Artery DiseaseKaplan-Meier EstimateAngina PectorisCoronary artery diseasePredictive Value of TestsRisk FactorsInternal medicineDiabetes mellitusEpidemiologyGlucose IntolerancemedicineDiabetes MellitusPrevalenceHumansObesityProspective StudieseducationProspective cohort studySicilyAgedMetabolic Syndromeeducation.field_of_studybusiness.industryIncidence (epidemiology)IncidenceFastingMiddle Agedmedicine.diseaseCardiovascular diseaseObesityStrokeEndocrinologyCardiovascular DiseasesFemaleMetabolic syndromeCardiology and Cardiovascular MedicinebusinessFollow-Up StudiesAtherosclerosis
researchProduct

Glycated serum proteins and glucose tolerance

1988

Glycated serum proteins (GSP), stable glycated hemoglobin (HbA1c) together with some metabolic parameters were evaluated in 120 subjects, 30 with normal glucose tolerance (NGT), 30 with impaired glucose tolerance (IGT), 30 with non-insulin-dependent diabetes mellitus (NIDD), and 30 with insulin-dependent diabetes mellitus (IDD). GSP levels were significantly higher in IGT, NIDD and IDD than in NGT. HbA1c levels were not significantly higher in IGT in comparison with NGT, but were significantly higher in NIDD and in IDD than in NGT and IGT. GSP correlated better than HbA1c with all metabolic parameters considered. Taking into account the distribution of the values, GSP showed a smaller overl…

AdultBlood GlucoseMalemedicine.medical_specialtyGlycosylationendocrine system diseasesEndocrinology Diabetes and MetabolismImpaired glucose toleranceHba1c levelchemistry.chemical_compoundEndocrinologystomatognathic systemReference ValuesInternal medicineDiabetes mellitusInternal MedicinemedicineHumansTriglyceridesGlycated HemoglobinGlucose tolerance testmedicine.diagnostic_testbusiness.industryCholesterolnutritional and metabolic diseasesBlood ProteinsGeneral MedicineGlucose Tolerance TestMiddle Agedmedicine.diseaseBlood proteinsCholesterolDiabetes Mellitus Type 1EndocrinologyDiabetes Mellitus Type 2chemistryHyperglycemiaMetabolic control analysisFemaleGlycated hemoglobinbusinesshormones hormone substitutes and hormone antagonistsActa Diabetologica Latina
researchProduct

A low reported energy intake is associated with metabolic syndrome.

2009

Background and aims: Metabolic syndrome (MS) may be associated with the presence of an energy sparing metabolism that predisposes to the excess accumulation of body fat. This study examined the relationship between reported energy intake and obesity in individuals with and without MS. Methods and results: Ninety consecutive non-diabetic obese subjects were divided into two groups based on the presence (MS+: n= 50) or absence (MS-: n= 40) of metabolic syndrome. The study design was cross-sectional. The three-day food record method was used to assess the subjects' usual energy intake and the Diet Readiness Test (DRT) was also administered. Compared to the MS- group, the MS+ group had a signif…

AdultBlood GlucoseMalemedicine.medical_specialtyMetabolic syndrome energy intake obesityEndocrinology Diabetes and MetabolismBlood PressureBody weightFat massBody Mass IndexEndocrinologyHeart RateInternal medicinemedicineHumansInsulinObesityMetabolic SyndromeInsulin bloodbusiness.industryBody Weightmedicine.diseaseObesityFood recordEndocrinologyBody CompositionLinear ModelsObese subjectsFemaleBasal MetabolismMetabolic syndromebusinessEnergy IntakeBody mass index
researchProduct

Body weight variation and control of cardiovascular risk factors in essential hypertension.

2009

The objective was to assess the impact of weight changes on blood pressure (BP), lipids and glucose goals in a cohort of hypertensive subjects.Prospective follow-up.Hypertension clinic.326 hypertensive non-diabetic subjects, 46% with metabolic syndrome (MS).Usual care treatment, which included diet, physical exercise and drugs prescribed when indicated. All patients were observed for up to 1 year.BP and low-density lipoprotein-cholesterol (LDL-C) goal were those in ESH/ESC and ATP III recommendations, respectively. The glucose goal was to delay progression to type 2 diabetes mellitus, or to achieve blood glucose100 mg/dl for non-diabetics. According to body weight changes, patients were cat…

AdultBlood GlucoseMalemedicine.medical_specialtyPhysical exerciseBlood PressureEssential hypertensionWeight GainCohort StudiesRisk FactorsInternal medicineWeight LossInternal MedicinemedicineHumansProspective StudiesProspective cohort studyMetabolic Syndromebusiness.industryType 2 Diabetes MellitusGeneral MedicineMiddle Agedmedicine.diseaseLipidsDietExercise TherapyBlood pressureEndocrinologyCardiovascular DiseasesCohortHypertensionFemaleMetabolic syndromeCardiology and Cardiovascular MedicinebusinessCohort studyFollow-Up StudiesBlood pressure
researchProduct

Prediction of incident type 2 diabetes mellitus based on a twenty-year follow-up of the Ventimiglia heart study.

2011

A novel algorithm to predict incident type 2 diabetes mellitus (iT2DM) is presented considering data from a 20-year prospective study in a Southern Italy population. Eight hundred and fifty-eight out of 1,351 subjects (24-85 years range of age) were selected. Incident type 2 diabetes was diagnosed in 103 patients in a 20-year follow-up. The Finnish Diabetes Risk Score (FINDRISC) and the Framingham Offspring Study simple clinical model (FOS) have been used as reference algorithms. Two custom algorithms have been created using Cox parametric hazard models followed by PROBIT analyses: the first one (VHSRISK) includes all the study subjects and the second one (VHS95RISK) evaluates separately su…

AdultBlood GlucoseMalemedicine.medical_specialtySettore MED/09 - Medicina InternaEndocrinology Diabetes and MetabolismPopulationType 2 diabetesLower riskBody Mass IndexYoung AdultEndocrinologyDiabetes mellitusInternal medicineInternal MedicinemedicineHumansProspective StudieseducationPopulation study Epidemiology Predictive models Incident diabetes mellitusAgedProportional Hazards ModelsAged 80 and overeducation.field_of_studyFramingham Risk Scorebusiness.industryType 2 Diabetes MellitusGeneral MedicineCholesterol LDLFastingMiddle Agedmedicine.diseaseSurgeryDiabetes Mellitus Type 2ItalyPopulation studyFemaleMetabolic syndromebusinessFollow-Up StudiesActa diabetologica
researchProduct